LINDSEY LANE: Open Payments
NPI 1497360606 · WHEATON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,008 in 53 payments from 13 companies in 2025. Trend: 2023 $633 · 2024 $1,124 · 2025 $1,008
Food & beverage: $1,008
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $236 |
| Amgen Inc. | 14 | $175 |
| Otsuka America Pharmaceutical, Inc. | 4 | $104 |
| AstraZeneca Pharmaceuticals LP | 5 | $101 |
| GlaxoSmithKline, LLC. | 3 | $90 |
| Lilly USA, LLC | 3 | $72 |
| Novo Nordisk Inc | 2 | $50 |
| BETA BIONICS, INC. | 2 | $47 |
| Esperion Therapeutics, Inc. | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $31 |
Products named: QULIPTA, OTEZLA, REXULTI, UBRELVY, TRELEGY ELLIPTA, AIRSUPRA, MOUNJARO, iLet Bionic Pancreas.
Industry payments across IL — which companies pay providers there.
